Annual EBITDA
-$54.00 M
+$19.02 M+26.05%
December 31, 2023
Summary
- As of February 8, 2025, VAXX annual EBITDA is -$54.00 million, with the most recent change of +$19.02 million (+26.05%) on December 31, 2023.
- During the last 3 years, VAXX annual EBITDA has fallen by -$15.95 million (-41.90%).
- VAXX annual EBITDA is now -296.48% below its all-time high of -$13.62 million, reached on December 31, 2019.
Performance
VAXX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$10.75 M
+$1.55 M+12.59%
December 31, 2023
Summary
- As of February 8, 2025, VAXX quarterly EBITDA is -$10.75 million, with the most recent change of +$1.55 million (+12.59%) on December 31, 2023.
- Over the past year, VAXX quarterly EBITDA has increased by +$8.91 million (+45.32%).
- VAXX quarterly EBITDA is now -57.13% below its all-time high of -$6.84 million, reached on June 30, 2020.
Performance
VAXX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$54.01 M
+$8.91 M+14.16%
December 31, 2023
Summary
- As of February 8, 2025, VAXX TTM EBITDA is -$54.01 million, with the most recent change of +$8.91 million (+14.16%) on December 31, 2023.
- Over the past year, VAXX TTM EBITDA has increased by +$19.02 million (+26.05%).
- VAXX TTM EBITDA is now -689.09% below its all-time high of -$6.84 million, reached on June 30, 2020.
Performance
VAXX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VAXX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.1% | +45.3% | +26.1% |
| 3 y3 years | -41.9% | +9.8% | -55.8% |
| 5 y5 years | -296.5% | -57.1% | -689.1% |
VAXX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.1% | at high | +77.4% | at high | +60.1% |
| 5 y | 5-year | -296.5% | +60.1% | -57.1% | +77.4% | -689.1% | +60.1% |
| alltime | all time | -296.5% | +60.1% | -57.1% | +77.4% | -689.1% | +60.1% |
Vaxxinity EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$54.00 M(-26.0%) | -$10.75 M(-12.6%) | -$54.01 M(-14.2%) |
| Sep 2023 | - | -$12.30 M(-7.5%) | -$62.92 M(-9.3%) |
| Jun 2023 | - | -$13.30 M(-24.6%) | -$69.39 M(-4.7%) |
| Mar 2023 | - | -$17.64 M(-10.3%) | -$72.84 M(-0.2%) |
| Dec 2022 | -$73.02 M(-46.0%) | -$19.67 M(+4.7%) | -$73.03 M(-27.6%) |
| Sep 2022 | - | -$18.78 M(+12.1%) | -$100.93 M(-9.9%) |
| Jun 2022 | - | -$16.75 M(-6.0%) | -$112.07 M(-8.0%) |
| Mar 2022 | - | -$17.82 M(-62.5%) | -$121.83 M(-9.9%) |
| Dec 2021 | -$135.23 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$47.57 M(+59.0%) | -$135.23 M(+35.8%) |
| Sep 2021 | - | -$29.91 M(+12.8%) | -$99.58 M(+16.4%) |
| Jun 2021 | - | -$26.52 M(-15.1%) | -$85.56 M(+29.9%) |
| Mar 2021 | - | -$31.23 M(+162.0%) | -$65.89 M(+90.1%) |
| Dec 2020 | -$38.06 M(+179.4%) | - | - |
| Dec 2020 | - | -$11.92 M(-25.0%) | -$34.66 M(+52.4%) |
| Sep 2020 | - | -$15.89 M(+132.2%) | -$22.74 M(+232.2%) |
| Jun 2020 | - | -$6.84 M | -$6.84 M |
| Dec 2019 | -$13.62 M | - | - |
FAQ
- What is Vaxxinity annual EBITDA?
- What is the all time high annual EBITDA for Vaxxinity?
- What is Vaxxinity annual EBITDA year-on-year change?
- What is Vaxxinity quarterly EBITDA?
- What is the all time high quarterly EBITDA for Vaxxinity?
- What is Vaxxinity quarterly EBITDA year-on-year change?
- What is Vaxxinity TTM EBITDA?
- What is the all time high TTM EBITDA for Vaxxinity?
- What is Vaxxinity TTM EBITDA year-on-year change?
What is Vaxxinity annual EBITDA?
The current annual EBITDA of VAXX is -$54.00 M
What is the all time high annual EBITDA for Vaxxinity?
Vaxxinity all-time high annual EBITDA is -$13.62 M
What is Vaxxinity annual EBITDA year-on-year change?
Over the past year, VAXX annual EBITDA has changed by +$19.02 M (+26.05%)
What is Vaxxinity quarterly EBITDA?
The current quarterly EBITDA of VAXX is -$10.75 M
What is the all time high quarterly EBITDA for Vaxxinity?
Vaxxinity all-time high quarterly EBITDA is -$6.84 M
What is Vaxxinity quarterly EBITDA year-on-year change?
Over the past year, VAXX quarterly EBITDA has changed by +$8.91 M (+45.32%)
What is Vaxxinity TTM EBITDA?
The current TTM EBITDA of VAXX is -$54.01 M
What is the all time high TTM EBITDA for Vaxxinity?
Vaxxinity all-time high TTM EBITDA is -$6.84 M
What is Vaxxinity TTM EBITDA year-on-year change?
Over the past year, VAXX TTM EBITDA has changed by +$19.02 M (+26.05%)